Europese Unie - Nederlands - EMA (European Medicines Agency)

sanofi pasteur - chimeric yellow fever dengue virus serotype 1 (live, attenuated), chimeric yellow fever dengue virus serotype 2 (live, attenuated), chimeric yellow fever dengue virus serotype 3 (live, attenuated), chimeric yellow fever dengue virus serotype 4 (live, attenuated) - dengue - vaccins - dengvaxia is indicated for the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4 in individuals 6 to 45 years of age with test-confirmed previous dengue infection (see sections 4. 2, 4. 4 en 4. het gebruik van dengvaxia moet gebeuren in overeenstemming met officiële aanbevelingen.

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

kernfarm b.v. - levend infectieus runderrhinotracheitisvirus - lyofilisaat voor suspensie voor injectie - bovine rhinotracheitis virus vaccine (ibr)

Europese Unie - Nederlands - EMA (European Medicines Agency)

laboratorios hipra, s.a. - levende, verzwakte infectieuze bursitis disease virus (ibdv), stam 1052 - immunologicals voor aves, domestic fowl, levende virale vaccins, vogel-infectieuze bursitis disease virus (gumboro ziekte) - chicken; embryonated chicken eggs - voor de actieve immunisatie van 1 dag oud broiler chicks en embryonale grill kip eieren aan het verminderen van klinische symptomen en letsels van de bursa van fabricius veroorzaakt door de zeer virulente vogelgriep infectieuze bursitis disease virus infectie.

Europese Unie - Nederlands - EMA (European Medicines Agency)

bavarian nordic a/s - vibrio cholerae, stam cvd-103-hgr, live - cholera - vaccins - vaxchora is indicated for active immunisation against disease caused by vibrio cholerae serogroup o1 in adults and children aged 2 years and older. dit vaccin moet worden gebruikt in overeenstemming met de officiële aanbevelingen.

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

zoetis belgium sa-nv - levend, geattenueerd, hondenpara-influenzavirus ; levend, geattenueerd, bordetella bronchiseptica - neusdruppels, lyofilisaat en oplosmiddel voor suspensie - levend, geattenueerd, bordetella bronchiseptica; hondenpara-influenzavirus type 2 - bordetella + canine parainfluenza virus - hond

Europese Unie - Nederlands - EMA (European Medicines Agency)

intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - immunologicals voor aves - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

lyofilisaat voor suspensie voor injectie - bovine rhinotracheitis virus vaccine (ibr)

Europese Unie - Nederlands - EMA (European Medicines Agency)

ceva-phylaxia veterinary biologicals co. ltd - turkey herpes virus, strain rhvt/nd/ibd, expressing the fusion protein of newcastle disease virus and the vp2 protein of infectious bursal disease virus, live recombinant - immunologicals voor aves - embryonated chicken eggs; chicken - for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs to reduce mortality, clinical signs and lesions caused by newcastle disease virus (ndv) and to reduce virus shedding; to reduce mortality, clinical signs and bursa lesions caused by very virulent infectious bursal disease virus (ibdv); to reduce mortality, clinical signs and lesions caused by classical marek’s disease virus (mdv).

Europese Unie - Nederlands - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live - kip - for active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.

Europese Unie - Nederlands - EMA (European Medicines Agency)

takeda gmbh - dengue virus, serotype 2, expressing dengue virus, serotype 1, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 3, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 4, surface proteins, live, attenuated, dengue virus, serotype 2, live, attenuated - dengue - vaccins - qdenga is indicated for the prevention of dengue disease in individuals from 4 years of age. the use of qdenga should be in accordance with official recommendations.